Literature DB >> 20542848

Rapid improvement in fasting lipids and hepatic toxicity after switching from didanosine/lamivudine to tenofovir/emtricitabine in patients with toxicity attributable to didanosine.

R Palacios, A Rivero, I Santos, M J Ríos, M Castaño, A del Arco, Jesús Santos González.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20542848     DOI： 10.1310/hct1102-118

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN： 1528-4336


× No keyword cloud information.
  3 in total

Review 1.  Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.

Authors:  Maxwell O Akanbi; Kimberly K Scarsi; Kimberly Scarci; Babafemi Taiwo; Robert L Murphy
Journal:  Expert Opin Pharmacother       Date:  2012-01       Impact factor: 3.889

2.  Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.

Authors:  José Ramón Santos; María Saumoy; Adrian Curran; Isabel Bravo; Jordi Navarro; Carla Estany; Daniel Podzamczer; Esteban Ribera; Eugenia Negredo; Bonaventura Clotet; Roger Paredes
Journal:  J Int AIDS Soc       Date:  2014-11-02       Impact factor: 5.396

3.  Anti-HIV Drugs Cause Mitochondrial Dysfunction in Monocyte-Derived Macrophages.

Authors:  Jennillee Wallace; Hemil Gonzalez; Reshma Rajan; Srinivas D Narasipura; Amber K Virdi; Arnold Z Olali; Ankur Naqib; Zarema Arbieva; Mark Maienschein-Cline; Lena Al-Harthi
Journal:  Antimicrob Agents Chemother       Date:  2022-03-16       Impact factor: 5.938
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.